The 510(k) decision clears the company to challenge Siemens Healthineers for an emerging part of the CT imaging sector.
GE HealthCare (Nasdaq: GEHC) has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for Photonova™ ...
Photonova Spectra i is the first in the next generation of spectral photon counting CT systems with 8-bins of energy resolution, powered by GE HealthCare’s proprietary Deep Silicon detector technology ...
How Investors Are Reacting To GEHC’s FDA-Cleared Photon-Counting CT And New Cardiology Platform Push
In late March 2026, GE HealthCare Technologies received U.S. FDA 510(k) clearance for its Photonova Spectra photon-counting ...
FDA clearance quickly follows Photonova Spectra’s debut at the Radiological Society of North America (RSNA) 2025 Annual Meeting, marking rapid momentum for GE HealthCare’s innovative photon-counting ...
GE HealthCare (Nasdaq: GEHC) has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for Photonova™ Spectra, i an innovative photon‑counting computed tomography (PCCT) solution ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results